SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Exelixis, Inc. (EXEL)
An SI Board Since January 2001
Posts SubjectMarks Bans Symbol
930 66 0 EXEL
Emcee:  kinkblot Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
330Exelixis Initiates Phase II Trial of XL880 in Patients with Gastric Cancer Fridamopgcw-12/22/2006
329Exelixis Files IND Application for XL518 Wednesday December 20, 6:00 am ET SOUTnigel bates-12/20/2006
328Exelixis and Bristol-Myers Squibb Sign New Collaboration Agreement to Discover anigel bates-12/18/2006
327gs: 52-Week Range US$12-8 YTD Price Change -5.84% Market Cap US$746.6mn Whatmopgcw-12/8/2006
326Part of today's WSJ article about PFE... <An emerging new approach is tokenhott-12/5/2006
325Exelixis Places XL999 Clinical Trial On Partial Hold Dec 4, 2006 13:15:00 (ET)LJM-12/4/2006
324On December 1, 2006, in a discussion with representatives from the Food and Drugdr.praveen-12/4/2006
323This is all I have found anyone else have more details? Exelixis Places XL999 CLJM-12/4/2006
322Artemis Signs Agreement With Merck & Co., Inc. for Generation of Geneticallynigel bates-11/20/2006
321Nice to see Exel go up today. One boring program(119)gone without wasting more mdr.praveen-11/17/2006
320Go figure. It's up on the news.rkrw-11/17/2006
319Not a significant program for Exel and a small market in comparision to 999. I ddr.praveen-11/16/2006
318Helsinn to Discontinue Becatecarin Trial Program Nov 16, 2006 16:00:00 (ET) SLJM-11/16/2006
317homecoming week, where are the floats?scaram(o)uche-11/9/2006
316>>my, my..... Tommysdad made a post today, too. Something in the air?<&tuck-11/9/2006
315Exelixis Presents Preliminary Phase I XL184 Data Thursday November 9, 6:00 am ETkenhott-11/9/2006
314Exelixis Reports Additional Data From a Phase I Trial of XL647 in Patients With kenhott-11/9/2006
313Exelixis Presents Updated Phase I XL880 Data at EORTC Conference Thursday Novembkenhott-11/9/2006
312my, my..... Tommysdad made a post today, too. Something in the air?scaram(o)uche-11/8/2006
311As you know Anthracyclines cause LVEF reduction, or the more severe congestive hdr.praveen-11/8/2006
310sfgate.com A crowded field in cancer research Hundreds of test therapies in thPseudo Biologist-11/8/2006
309re: x999. If I have this right, it looks like they had the best responses at thkeokalani'nui-11/8/2006
308Reference: Exelixis drugs,targets & Indications Drug,Target,Status,Indicatidr.praveen-11/8/2006
307Phase I Data for Exelixis' Kit Inhibitor XL820 Presented at EORTC Wednesday dr.praveen-11/8/2006
306Exelixis Reports Additional Data From the Phase I Trial of XL999 in Patients Witdr.praveen-11/8/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News